Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › CGON

FARALLON CAPITAL MANAGEMENT, L.L.C. position in CGON

CG ONCOLOGY INC · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 400,000 shares of CGON (CG ONCOLOGY INC) in its Q2 2026 13F filing — a position valued at US$28.4M, representing 0.13% of its reported portfolio and ranking #44 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed CGON holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)400.00K sh
Reported value held$28.42M
Portfolio Weight0.13%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s CGON position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in CGON in Q2 2025 at 8,000 shares (US$208K). The position peaked in Q2 2026 at 400,000 shares, worth US$28.4M. Across 5 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 400,000 shares valued at US$28.4M — an increase of 200,000 shares quarter over quarter.. Notable position changes include a 2400% increase in Q1 2026 (shares rose 5% over the following quarter), a 100% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 8.00K $208.00K New
Q3 2025 8.00K $322.24K Hold
Q4 2025 8.00K $332.16K Hold
Q1 2026 200.00K $13.54M Add
Q2 2026 400.00K $28.42M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGON and 13F data

CGON (CG ONCOLOGY INC) is a Health Care company. 52 other funds we track also report a position in CGON — the largest reported positions include RTW INVESTMENTS, LP (US$605.0M), Decheng Capital LLC (US$452.7M), TCG Crossover Management, LLC (US$260.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGON

All CGON fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held CGON?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed CGON holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in CGON?

As of Q2 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 400.00K shares of CGON (CG ONCOLOGY INC), valued at $28.42M, representing 0.13% of its reported portfolio and ranking #44.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling CGON?

In the latest 13F filing (Q2 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. increased its position in CGON. The position peaked in Q2 2026 at 400.00K shares.

Which other funds hold CGON?

Other major institutional holders of CGON include RTW INVESTMENTS, LP, Decheng Capital LLC, TCG Crossover Management, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.